Tumor Microenvironment in Sporadic Vestibular Schwannoma: A Systematic, Narrative Review
- PMID: 37047498
- PMCID: PMC10094882
- DOI: 10.3390/ijms24076522
Tumor Microenvironment in Sporadic Vestibular Schwannoma: A Systematic, Narrative Review
Abstract
Although diagnosis and treatment of vestibular schwannomas (VSs) improved in recent years, no factors have yet been identified as being capable of predicting tumor growth. Molecular rearrangements occur in neoplasms before any macroscopic morphological changes become visible, and the former are the underlying cause of disease behavior. Tumor microenvironment (TME) encompasses cellular and non-cellular elements interacting together, resulting in a complex and dynamic key of tumorigenesis, drug response, and treatment outcome. The aim of this systematic, narrative review was to assess the level of knowledge on TME implicated in the biology, behavior, and prognosis of sporadic VSs. A search (updated to November 2022) was run in Scopus, PubMed, and Web of Science electronic databases according to the PRISMA guidelines, retrieving 624 titles. After full-text evaluation and application of inclusion/exclusion criteria, 37 articles were included. VS microenvironment is determined by the interplay of a dynamic ecosystem of stromal and immune cells which produce and remodel extracellular matrix, vascular networks, and promote tumor growth. However, evidence is still conflicting. Further studies will enhance our understanding of VS biology by investigating TME-related biomarkers able to predict tumor growth and recognize immunological and molecular factors that could be potential therapeutic targets for medical treatment.
Keywords: acoustic neuroma; angiogenesis; inflammation; macrophage; skull base; tumor microenvironment; vestibular schwannoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.J Neurosurg. 2020 May 29;134(5):1419-1429. doi: 10.3171/2020.3.JNS193230. Print 2021 May 1. J Neurosurg. 2020. PMID: 32470937
-
Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics.Otol Neurotol. 2015 Aug;36(7):1128-36. doi: 10.1097/MAO.0000000000000788. Otol Neurotol. 2015. PMID: 26049313 Review.
-
Giant Sporadic Unilateral Vestibular Schwannoma in Child: Can It Get Bigger Than This?World Neurosurg. 2019 Oct;130:378-379. doi: 10.1016/j.wneu.2019.07.064. Epub 2019 Jul 12. World Neurosurg. 2019. PMID: 31306840
-
M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma.Virchows Arch. 2019 Mar;474(3):375-381. doi: 10.1007/s00428-018-2503-1. Epub 2018 Dec 22. Virchows Arch. 2019. PMID: 30580386 Free PMC article.
-
Contemporary Molecular Biology of Sporadic Vestibular Schwannomas: A Systematic Review and Clinical Implications.J Int Adv Otol. 2018 Aug;14(2):322-329. doi: 10.5152/iao.2018.4929. J Int Adv Otol. 2018. PMID: 30100540 Free PMC article.
Cited by
-
Current molecular understanding of central nervous system schwannomas.Acta Neuropathol Commun. 2025 Feb 5;13(1):24. doi: 10.1186/s40478-025-01937-w. Acta Neuropathol Commun. 2025. PMID: 39910685 Free PMC article. Review.
-
A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis.Pharmaceuticals (Basel). 2023 Sep 11;16(9):1282. doi: 10.3390/ph16091282. Pharmaceuticals (Basel). 2023. PMID: 37765090 Free PMC article.
-
Prediction of treatment failure and early identification of tumor progression after Gamma-Knife radiosurgery in vestibular schwannoma: A retrospective cohort study.Neurooncol Adv. 2025 Jun 24;7(1):vdaf139. doi: 10.1093/noajnl/vdaf139. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 40756668 Free PMC article.
-
Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations.Front Oncol. 2024 May 16;14:1340184. doi: 10.3389/fonc.2024.1340184. eCollection 2024. Front Oncol. 2024. PMID: 38817895 Free PMC article.
-
Long-Term Hearing Outcome For Vestibular Schwannomas After Microsurgery And Radiotherapy: A Systematic Review and Meta-Analysis.Otolaryngol Head Neck Surg. 2024 Dec;171(6):1670-1681. doi: 10.1002/ohn.910. Epub 2024 Jul 24. Otolaryngol Head Neck Surg. 2024. PMID: 39045727 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical